Company Description
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions.
This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics.
The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors.
It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes.
The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.
Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
| Country | United States |
| Founded | 1978 |
| IPO Date | Feb 1, 1995 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 3,500 |
| CEO | John P. Marotta |
Contact Details
Address: 200 Summit Drive Burlington, Massachusetts 01803 United States | |
| Phone | 978 262 2626 |
| Website | azenta.com |
Stock Details
| Ticker Symbol | AZTA |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000933974 |
| CUSIP Number | 114340102 |
| ISIN Number | US1143401024 |
| Employer ID | 04-3040660 |
| SIC Code | 3559 |
Key Executives
| Name | Position |
|---|---|
| Luc Provost | Vice President and Chief Executive Officer of B Medical Systems |
| John P. Marotta | President and Chief Executive Officer |
| Robin Vacha | Senior Vice President of Global Operations |
| Violetta Hughes | Vice President and Chief Accounting Officer |
| Michael Paulo | Vice President and Chief Information and Digital Officer |
| John E. O'Brien | Senior Vice President of Corporate Development |
| Olga Pirogova | Senior Vice President and Chief Human Resources Officer |
| J. Robert Woodward | Senior Vice President of Global Quality and Regulatory |
| Dr. Ginger Zhou Ph.D. | Senior Vice President and GM of Multiomics and Synthesis Solutions |
| David Wang | Senior Vice President and GM of Sample Management Solutions |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Nov 12, 2024 | 8-K | Current Report |
| Nov 4, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Nov 4, 2024 | 8-K | Current Report |
| Oct 31, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Sep 4, 2024 | 8-K | Current Report |
| Aug 6, 2024 | 10-Q | Quarterly Report |
| Aug 6, 2024 | 8-K | Current Report |
| Aug 1, 2024 | 144 | Filing |
| Jul 25, 2024 | 144 | Filing |